What Psomagen does

Psomagen, Inc. is a US-based Contract Research Organization providing integrative multiomics laboratory and bioinformatics services to academic, pharmaceutical, biotechnology, and clinical diagnostic customers. Founded in 2002 (originally as Macrogen Corp/USA, later rebranded to Psomagen), the company is a wholly-owned subsidiary of Macrogen (주식회사 마크로젠), a South Korean genomics company publicly traded on the KOSDAQ exchange. Psomagen operates four CLIA-certified and CAP-accredited laboratories across the United States, headquartered in Rockville, MD with an additional office in Cambridge, MA, and employs 51-100 people.

The company's service portfolio spans eight omics disciplines — genomics, epigenomics, transcriptomics, metagenomics, proteomics, single-cell sequencing, spatial biology, and bioinformatics — supported by best-in-class platforms from 10x Genomics, Illumina, PacBio, Oxford Nanopore, NanoString, Olink, Parse Biosciences, and OmicInsight. Psomagen holds exclusive US Certified Service Provider status for 10x Genomics Single Cell Multiome ATAC + Gene Expression and Single Cell ATAC, was the first US commercial acquirer of the Xenium Analyzer (June 2023), and is the first global CRO committed to deploying the Atera platform (2026). Differentiated offerings include the Cellanome R3200 service using proprietary CellCage technology for matched live-cell imaging and transcriptomics, and a Cell Line Authentication service using 24-locus STR profiling.

Psomagen operates a hybrid B2B go-to-market combining consultative enterprise field sales for complex multiomics projects with a self-serve online ordering portal (order.psomagen.com) for standardized services such as Sanger sequencing. Revenue is generated primarily on a per-sample or per-project transaction basis, with supplementary bioinformatics, premade library, and rapid-turnaround (FAST-Seq/RNA/Meta) service lines. Pricing is quote-based and not publicly disclosed. Customer evidence includes named engagements with Moderna, the National Cancer Institute, the University of Nebraska-Lincoln Schnable Lab, and long-tenured academic customers such as a University of Maryland scientist reporting a decade of repeat Sanger sequencing business. The company's clinical services (CLIA WGS, WES, Sanger, variant confirmation, LDT) extend its reach into regulated diagnostic workflows.

Name

Psomagen

Legal name

Psomagen, Inc.

Website

https://psomagen.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

Psomagen is a US-based multiomics Contract Research Organization serving academic, pharmaceutical, biotechnology, and clinical diagnostic customers with genomics, transcriptomics, epigenomics, proteomics, single-cell, and spatial biology services delivered through four CLIA-certified and CAP-accredited laboratories. The company is a subsidiary of South Korea's Macrogen.

Ownership category

akta.pro rank

Product category

Genomics and Multiomics Contract Research Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industries

Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Epigenomics & Chromatin Profiling Services (HLAGANAF), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)

Keywords

• Multiomics contract research
• Next-generation sequencing
• Single-cell sequencing
• Spatial biology services
• Clinical genomic testing

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Research Services (Sequencing): Laboratory services revenue from providing DNA/RNA sequencing services including whole genome sequencing, whole exome sequencing, Sanger sequencing, targeted sequencing, metagenomics, long-read sequencing, and single-cell sequencing. Billed per sample or per project based on sequencing depth and sample count. Standard WGS generates approximately 90 Gb of data per sample; WES generates approximately 10 Gb per sample.
2. Bioinformatics and Data Analysis Services: NGS data analysis and custom data analysis services. Bioinformatics deliverables include raw sequencing data, expression visualizations, cell identification, and summary reports. Billed as part of sequencing projects or as standalone analysis services.
3. Clinical/CLIA Services: CLIA-certified laboratory services for clinical diagnostics including CLIA Whole Genome Sequencing, CLIA Whole Exome Sequencing, CLIA Sanger Sequencing, and CLIA Variant Confirmation. LDT (Laboratory Developed Test) services.
4. Spatial Biology Services: Spatial transcriptomics and proteomics services using 10x Genomics Visium HD, Xenium, Atera, NanoString CosMx, and OmicInsight Esper platforms. Revenue generated per slide or per tissue section processed.
5. Proteomics Services: Olink Proteomics services including Explore 1536 & 3072 Platform, Target 96 Panels, Target 48 Cytokine, and Focus 21 Custom Panels for protein biomarker discovery.
6. Premade Libraries: Ready-to-run library products including NovaSeq X Plus Premade Libraries, UG 100 Premade Libraries, and Revio Premade Libraries for customers who want to run their own sequencing with pre-prepared library reagents.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Psomagen is a US-based contract research organization providing integrated multiomics laboratory services spanning genomics, epigenomics, transcriptomics, metagenomics, proteomics, single-cell sequencing, and spatial biology. Services are delivered through four CLIA-certified and CAP-accredited US laboratories (Rockville, MD headquarters and Cambridge, MA) using best-in-class platforms from Illumina, 10x Genomics, PacBio, Oxford Nanopore, NanoString, Olink, Parse Biosciences, and Cellanome. The offering includes clinical-grade CLIA testing, bioinformatics analysis, premade libraries, and rapid-turnaround FAST-Seq services for academic, pharmaceutical, biotech, and clinical diagnostic customers.

Product overview

Psomagen is a US-based Contract Research Organization (CRO) offering integrative multiomics services as a unified platform of laboratory and bioinformatics services. The portfolio spans genomics (WGS, WES, Sanger, targeted panels, microarray), epigenomics (bisulfite sequencing, ATAC-seq), transcriptomics (total RNA, mRNA, small RNA, long-read Iso-Seq), metagenomics (shotgun, 16S/ITS, metatranscriptome), proteomics (Olink PEA-based multiplex panels), single-cell sequencing (10x Genomics Chromium/GEM-X, Parse Biosciences, Fluent BioSciences, PacBio long-read, Cellanome R3200), and spatial biology (10x Genomics Visium HD, Xenium, CytAssist; NanoString CosMx). Services include rapid-turnaround options (FAST-Seq, FAST-RNA, FAST-Meta), CLIA-certified clinical testing, bioinformatics data analysis, and quality control services (Cell Line Authentication). All services are delivered through CLIA-certified and CAP-accredited US laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

• Whole Genome Sequencing (WGS)
• Whole Exome Sequencing (WES)
• Sanger Sequencing
• Whole Plasmid Sequencing
• Bacterial Genome Sequencing
• Amplicon Sequencing
• Targeted Gene Sequencing
• Microarray Analysis
• Shotgun Metagenomic Sequencing
• 16S/ITS Amplicon Sequencing
• Metatranscriptome Sequencing
• Long-Read Metagenomic Sequencing
• Whole Genome Bisulfite Sequencing
• Reduced Representation Bisulfite Sequencing (RRBS)
• Total RNA Sequencing
• mRNA Sequencing
• Small RNA Sequencing
• Low Input RNA Sequencing
• Olink Proteomics
• 10x Genomics Visium HD Spatial Biology
• 10x Genomics Xenium Spatial Imaging
• NanoString CosMx Spatial Molecular Imager
• 10x Genomics Chromium Single-Cell Sequencing
• Parse Biosciences Single-Cell Sequencing
• Fluent BioSciences (Illumina Single-Cell) Sequencing
• PacBio Long-Read Single-Cell Sequencing
• Single-Cell Epi ATAC Sequencing
• Cellanome R3200 Services
• OmicInsight Esper Spatial Imaging
• 10x Genomics Atera Spatial Biology
• PacBio Revio Long-Read Sequencing
• Oxford Nanopore Long-Read Sequencing
• NGS Data Analysis / Bioinformatics
• FAST-RNA Sequencing
• FAST-Meta Sequencing
• Premade Sequencing Libraries
• CLIA Laboratory Developed Test (LDT) Service
• Cell Line Authentication (CLA)
• CAG and C9orf72 Repeat Analysis

Quantifiable outcome

• Sanger sequencing turnaround time as fast as 4 hours from sample receipt
• +5 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration15 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, supporting and planned.

• MacrogencoreStrategic or Co-development Partner · 28 April 2026Psomagen is the US subsidiary of Macrogen (formerly Macrogen Corp). Macrogen is a publicly held company on KOSDAQ (South Korean Stock Exchange). Psomagen serves as Macrogen's North American CRO operations, with joint commitment to deploy 10x Genomics Atera instruments as the first global service provider. Parent company relationship provides global reach and operational scale.
• OmicInsightcoreTechnology or Integration · 25 February 2026Partnership announced February 2026 for AI-powered high-resolution imaging and analysis for spatial biology. OmicInsight's Esper platform offers single-molecule sensitivity, subcellular resolution imaging, customizable analysis pipelines, and AI-powered workflows for RNA and protein co-detection. At Psomagen, Esper can be accessed as standalone or in conjunction with single-cell and spatial platforms as a validation tool.
• LevitasBiosupportingTechnology or Integration · 4 September 2024Psomagen deployed the LeviCell EOS system from LevitasBio to improve performance of cryo-preserved, antibody-labeled samples and nuclei isolations. The system uses gentle levitation to separate dead/dying cells and debris from viable samples, improving sample quality and success rates for single-cell sequencing experiments.
• BioSkrybplannedTechnology or Integration · 4 September 2024Planned partnership for BioSkryb ResolveOME workflows in Q4 2024. Partnership will include investment in new equipment and personnel to bring high-quality single-cell services at scale.
• Parse BiosciencescoreTechnology or Integration · 29 July 2024Psomagen added Parse Biosciences combinatorial barcoding technology for single-cell applications in July 2024. Parse's instrument-free workflow enables 12-96 samples per run with up to 1 million cells per plate. Key capabilities include cell/nuclei fixation, long-term sample storage, VDJ enrichment, CRISPR screening, and targeted gene capture.
• 10x GenomicscoreTechnology or Integration · 1 January 2021Psomagen is a 10x Genomics Certified Service Provider (CSP) for 3' and 5' Single Cell Gene Expression, Single Cell Immune Profiling, Single Cell Multiome ATAC + Gene Expression, and Single Cell ATAC. The company is the only CSP in the United States to offer both Single Cell Multiome ATAC + Gene Expression and Single Cell ATAC. Psomagen was the first US commercial company to acquire the Xenium platform (June 2023) and the first global CRO to deploy the Atera platform (2026).
• Olink ProteomicscoreTechnology or Integration · 1 January 2021Partnership to offer Olink Proteomics services including Explore 1536 & 3072 Platform, Target 96 Panels, Target 48 Cytokine, and Focus 21 Custom Panels. Psomagen is an Olink-certified service provider, bringing end-to-end multiomics solutions to drug discovery and clinical research industries.
• CellanomesupportingTechnology or IntegrationPsomagen offers Cellanome R3200 services using proprietary CellCage technology for matched imaging and single-cell transcriptomes. CellCage enclosures (CCEs) isolate individual cells enabling longitudinal imaging during treatment combined with transcriptomic profiling. Subsidized pilot program offered between April 20 and June 30, 2026.
• NanoStringcoreTechnology or IntegrationPsomagen added NanoString CosMx Spatial Molecular Imager in October 2023 for high-plex spatial insights at cellular and subcellular resolution. NanoString's 6K-plex RNA assays enable deep cell identification and mechanism of action studies. Part of the Single Cell & Spatial Center of Excellence.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Genewiz (Azenta Life Sciences): Genewiz, now part of Azenta, is one of the largest US-based genomics CROs offering Sanger, NGS, and gene synthesis services to academic and pharma customers. It is the closest direct competitor to Psomagen's sequencing services portfolio and overlaps heavily on multiomics project work.
• Novogene: Novogene is a global genomics CRO offering WGS, WES, RNA-seq, single-cell, and bioinformatics services with significant US operations. It competes head-to-head with Psomagen on multiomics project pricing and turnaround for academic and pharma accounts.
• CD Genomics: CD Genomics is a sequencing and multiomics CRO offering WGS, RNA-seq, single-cell, and epigenomics services. It targets overlapping academic and pharma customers with a comparable project-based service model, making it a close competitor in the US market.
• Omega Bioservices: Omega Bioservices provides WGS, WES, RNA-seq, single-cell sequencing, and bioinformatics to academic and pharma clients. It competes with Psomagen on similar project scopes and customer segments, especially for translational research programs.
• Quintara Biosciences: Quintara Biosciences is a CRO providing Sanger, NGS, qPCR, and molecular biology services to academic and biotech customers. It competes directly with Psomagen on routine sequencing projects and pricing for smaller-volume orders.

Broad incumbents

• Eurofins Genomics: Eurofins Genomics is a division of Eurofins Scientific offering Sanger, NGS, oligonucleotide synthesis, and bioinformatics at much larger global scale. It serves overlapping customer segments with a broader menu, competing on price and global reach.
• BGI Genomics: BGI Genomics is a globally dominant genomics services provider offering WGS, WES, and multiomics at aggressive price points. It competes with Psomagen on large-scale sequencing projects, particularly for global pharma sponsors and population genomics initiatives.
• WuXi AppTec (Genomics Division): WuXi AppTec operates a large genomics and multiomics services arm supporting pharma R&D, including sequencing and bioinformatics. It is a broader incumbent with integrated drug development services, overlapping Psomagen's pharma biotech segment.
• Charles River Laboratories (Genomics & Cell Biology): Charles River Laboratories offers a broad portfolio of preclinical and genomics services including sequencing and cell biology. As a large diversified CRO, it competes with Psomagen for pharma/biotech multiomics work within larger end-to-end drug development contracts.

Emerging players

• SeqCenter: SeqCenter is a smaller US-based sequencing CRO focused on long-read and next-generation sequencing services. While narrower in scope than Psomagen, it is a relevant emerging competitor for academic accounts seeking affordable sequencing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/psomagen

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Psomagen